Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy. - Seremet, Teofila; Jansen, Yanina; Planken, Simon; Njimi, Hassan; Delaunoy, Mélanie; El Housni, Hakim; Awada, Gil; Schwarze, Julia Katharina; Keyaerts, Marleen; Everaert, Hendrik; Lienard, Danielle; Del Marmol, Véronique; et al. (Journal of Translational Medicine, 2019)